Back to search

National and Kapodistrian University of Athens

Προσδιορισμός της υπερέκφρασης βιολογικών δεικτών σε καρκινώματα του ενδομητρίου με ανοσοϊστοχημικές μεθόδους

Abstract

dc:description

Objective: Endometrial carcinoma is one of the most common malignancies of the female genital tract. Alterations in the expression levels of various oncogenes and tumor suppressor genes serve important roles in the carcinogenesis and biological behavior of endometrial carcinoma. Chronic hyperinsulinemia due to insulin resistance and elevated levels of insulin-like growth factor (IGF)-1 and IGF-2 are suggestive of a significantly higher risk of endometrial carcinoma. There is a wealth of evidence showing differential expression of IGF-1 isoforms in various types of cancer. Material and Methods: The aim of the present study was to evaluate retrospectively in 99 archived endometrial carcinoma tissue sections the immunohistochemical protein expression of p53, phosphatase and tensin homologue deleted on chromosome 10 (PTEN), survivin and IGF-1Ec isoform. In addition, the correlation of the expression of these proteins with clinicopathological parameters was assessed. Furthermore, the association was assessed between clinicopathological parameters and i) the concomitant expression of p53 and PTEN expression, ii) the concomitant expression of survivin and PTEN and p53 expression, and iii) the concomitant expression of IGF-1Ecisoform and PTEN, p53 or survivin. Expression of IGF-1Ec was also assessed in nine cases of non-neoplastic endometrial tissue adjacent to the tumor, in 30 cases with normal endometrium and in 30 cases with endometrial hyperplasia. Results: The overall rate of p53 and PTEN positivity was 89 and 77%, respectively, according to the sum of stain intensity and scores of immunopositive cells. Immunopositivity for survivin was identified in 88% of cases. IGF-1Ec expression was high in non-endometrioid carcinoma (serous papillary or clear cell carcinoma) compared with that in endometrioid adenocarcinoma. IGF-1Ec expression was also high in the presence of tumoral necrosis. Notably, the sum of the immunohistochemical expression of p53 was significantly correlated with patient age (P=0.037), histologic type (P=0.008), histologic grade (P=0.002) and fallopian and/or ovarian invasion (P=0.014). Furthermore, PTEN expression was associated with myometrial invasion(ρ=-0.377; P=0.002) and clinical stage (P=0.019). A significant association was identified between the sum of staining intensity and scores of survivin immunopositive cells, and patient age (P=0.028), histological grade (P<0.001), clinical stage (P=0.018) and fallopian tube and/or ovarian invasion (P=0.039). Furthermore, there was as ignificant correlation between the histological differentiation and the sum of stain ingintensity and the number of IGF-1Ec immunopositive cells in endometrial carcinoma. The concomitant sum of p53 and PTEN expression was identified in 45% of patients with endometrial adenocarcinoma. Concomitant survivin, PTEN and p53 expression (staining scores and intensity) was observed in 60% of endometrial adenocarcinomas. The sum of p53 positivity correlated strongly with PTEN expression (ρ=0.256;P=0.044). In addition, concomitant p53 and PTEN expression was correlated with patient age (P=0.008) and histologic differentiation (P=0.028). A negative tendency for correlation was observed between surivin and PTEN immunostaining scores (P=0.062;ρ=-0.238). Specimens with high scores of survivin expression tended to show decreased scores of PTEN immunostaining, and vice versa. However, in circumstances with an increased co-expression of survivin and PTEN, a statistically significant association with histological types was observed (P=0.020). A statistically significant positive correlation was identified between survivin and p53 sum co-expression (P=0.008;ρ=0.300). Furthermore, a significant association was identified between survivin and p53 concomitant sum expression and age of patients (P=0.001), histological type(P=0.020), clinical stage (P=0.037), histological differentiation (P=0.001) and presence of fallopian tube and/or ovarian invasion (P=0.026). In addition, there was a moderatenegative correlation between co-expression of IGF-1Ec and PTEN, for both the number of immunopositive cells (P=0.006, ρ=-0.343) and the sum of staining (scores and intensity; P=0.006, ρ=-0.343). Furthermore, there was a positive correlation between the sum of staining (scores and intensity) and co-expression of IGF-1Ec and survivin (P=0.043, ρ=0.225). However, there was no association between concomitant expression of IGF-1Ec and p53. Conclusions: The findings indicated a correlation between the expression of p53 and PTEN in endometrial adenocarcinoma, which suggested an intrinsic association between expression levels of these tumor suppressor genes. The study also suggested that concomitant p53 and PTEN expression contributed in characterizing the tumor behavior of endometrial carcinoma. Taken together, the present study suggested the combined expression of p53 and PTEN in the development of high-grade endometrial carcinoma in older patients. In addition, the findings indicated activation of different molecular pathways in the tumor progression between low-grade and high-gradeendometrial carcinomas. Also, the findings suggested that survivin may be an indicator of unfavorable outcome in older patients with endometrial carcinoma, in specific circumstances that are dependent on different concomitant genetic alterations and different combinations of molecular signaling pathways. Increased expression levels of survivin and PTEN may serve a role in the development of more aggressive endometrial carcinoma during their interaction. In addition, protein expression levels of survivin and p53 are positively correlated and may share a common molecular pathway to promote endometrial carcinogenesis. These findings provided evidence that survivin and p53 combined may be useful markers for the prediction of tumor behavior and prognosis. Finally, these results emphasized the importance of IGF-1Ec expression during development of non-estrogen dependent endometrial adenocarcinoma. IGF-1Ecand PTEN may function opposingly during endometrial carcinogenesis. By contrast,IGF-1Ec and survivin may share common molecular pathways and may promote, inparallel, tumoral development.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2021

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Stavropoulos, Aggelis
  • Σταυρόπουλος, Αγγέλης

Subjects

dc:subject × 12

Rights

dc:rights
Statement dc:rights
  • BY
Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/48884

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Stavropoulos, Aggelis; Σταυρόπουλος, Αγγέλης. Προσδιορισμός της υπερέκφρασης βιολογικών δεικτών σε καρκινώματα του ενδομητρίου με ανοσοϊστοχημικές μεθόδους. National and Kapodistrian University of Athens, 2021. http://hdl.handle.net/10442/hedi/48884